Log in | Register

On the verge of using an immune toolbox in the intensive care unit?

Frédéric Pène| Jean-Louis Vincent| Ignacio Martin-Loeches
Editorial
Volume 43, Issue 8 / August , 2017

Pages 1154 - 1156

No abstract available.

References

  1. Daviaud F, Grimaldi D, Dechartres A, Charpentier J, Geri G, Marin N, Chiche JD, Cariou A, Mira JP, Pène F (2015) Timing and causes of death in septic shock. Ann Intensive Care 5:16
    • View reference on publisher's website
    • View reference on PubMed
  2. van Vught LA, Klein Klouwenberg PM, Spitoni C, Scicluna BP, Wiewel MA, Horn J, Schultz MJ, Nurnberg P, Bonten MJ, Cremer OL, van der Poll T (2016) Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA 315:1469–1479
    • View reference on publisher's website
    • View reference on PubMed
  3. Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862–874
    • View reference on publisher's website
    • View reference on PubMed
  4. Zilahi G, Artigas A, Martin-Loeches I (2016) What’s new in multidrug-resistant pathogens in the ICU? Ann Intensive Care 6:96
    • View reference on publisher's website
    • View reference on PubMed
  5. Monneret G, Lepape A, Voirin N, Bohe J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P (2006) Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32:1175–1183
  6. Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Bohe J, Vanhems P, Monneret G (2010) Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36:1859–1866
  7. Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS (2014) Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock 42:383–391
    • View reference on publisher's website
    • View reference on PubMed
  8. Grimaldi D, Le Bourhis L, Sauneuf B, Dechartres A, Rousseau C, Ouaaz F, Milder M, Louis D, Chiche JD, Mira JP, Lantz O, Pène F (2014) Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med 40:192–201
  9. Adrie C, Lugosi M, Sonneville R, Souweine B, Ruckly S, Cartier JC, Garrouste-Orgeas M, Schwebel C, Timsit JF (2017) Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission. Ann Intensive Care 7:30
    • View reference on publisher's website
    • View reference on PubMed
  10. Shalova IN, Lim JY, Chittezhath M, Zinkernagel AS, Beasley F, Hernandez-Jimenez E, Toledano V, Cubillos-Zapata C, Rapisarda A, Chen J, Duan K, Yang H, Poidinger M, Melillo G, Nizet V, Arnalich F, Lopez-Collazo E, Biswas SK (2015) Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1alpha. Immunity 42:484–498
    • View reference on publisher's website
    • View reference on PubMed
  11. Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, Rautanen A, Gordon AC, Garrard C, Hill AV, Hinds CJ, Knight JC (2016) Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med 4:259–271
    • View reference on publisher's website
    • View reference on PubMed
  12. Peronnet E, Venet F, Maucort-Boulch D, Friggeri A, Cour M, Argaud L, Allaouchiche B, Floccard B, Aubrun F, Rimmelé T, Thiolliere F, Piriou V, Bohé J, Cazalis M, Barbalat V, Monneret G, Morisset S, Textoris J, Vallin H, Pachot A, Lepape A (2017) Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections. A multicenter cohort study. Intensive Care Med. doi:10.1007/s00134-017-4805-1
    • View reference on PubMed
  13. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk HD (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180:640–648
    • View reference on publisher's website
    • View reference on PubMed
  14. Grimaldi D, Pradier O, Hotchkiss RS, Vincent JL (2017) Nivolumab plus interferon-gamma in the treatment of intractable mucormycosis. Lancet Infect Dis 17:18
    • View reference on publisher's website
    • View reference on PubMed
  15. Venet F, Foray AP, Villars-Mechin A, Malcus C, Poitevin-Later F, Lepape A, Monneret G (2012) IL-7 restores lymphocyte functions in septic patients. J Immunol 189:5073–5081
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement